BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bradshaw DV Jr, Knutsen AK, Korotcov A, Sullivan GM, Radomski KL, Dardzinski BJ, Zi X, McDaniel DP, Armstrong RC. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures. Acta Neuropathol Commun 2021;9:89. [PMID: 34001261 DOI: 10.1186/s40478-021-01193-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Alexandris AS, Lee Y, Lehar M, Alam Z, Samineni P, Tripathi SJ, Ryu J, Koliatsos VE. Traumatic axonopathy in spinal tracts after impact acceleration head injury: Ultrastructural observations and evidence of SARM1-dependent axonal degeneration. Experimental Neurology 2023;359:114252. [DOI: 10.1016/j.expneurol.2022.114252] [Reference Citation Analysis]
2 Havlicek DF, Furhang R, Nikulina E, Smith-salzberg B, Lawless S, Severin SA, Mallaboeva S, Nayab F, Seifert AC, Crary JF, Bergold PJ. A single closed head injury in male adult mice induces chronic, progressive white matter atrophy and increased phospho-tau expressing oligodendrocytes. Experimental Neurology 2023;359:114241. [DOI: 10.1016/j.expneurol.2022.114241] [Reference Citation Analysis]
3 Wang S, Zhang Y, Lou J, Yong H, Shan S, Liu Z, Song M, Zhang C, Kou R, Liu Z, Yu W, Zhao X, Song F. The therapeutic potential of berberine chloride against SARM1-dependent axon degeneration in acrylamide-induced neuropathy. Phytother Res 2022. [PMID: 36054436 DOI: 10.1002/ptr.7594] [Reference Citation Analysis]
4 Radomski KL, Zi X, Lischka FW, Noble MD, Galdzicki Z, Armstrong RC. Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury. Acta Neuropathol Commun 2022;10:67. [PMID: 35501931 DOI: 10.1186/s40478-022-01366-z] [Reference Citation Analysis]
5 Lu Q, Botchway BOA, Zhang Y, Jin T, Liu X. SARM1 can be a potential therapeutic target for spinal cord injury. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04195-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Radomski KL, Zi X, Lischka FW, Noble MD, Galdzicki Z, Armstrong RC. Acute Axon Damage and Demyelination are Mitigated by 4-Aminopyridine (4-AP) Therapy after Experimental Traumatic Brain Injury.. [DOI: 10.1101/2022.01.27.477989] [Reference Citation Analysis]
7 DiAntonio A, Milbrandt J, Figley MD. The SARM1 TIR NADase: Mechanistic Similarities to Bacterial Phage Defense and Toxin-Antitoxin Systems. Front Immunol 2021;12:752898. [PMID: 34630431 DOI: 10.3389/fimmu.2021.752898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]